Vault-13

INOTEK PHARMACEUTICALS CORP RCKT 5.75 08.01.21

NOTE 5.750% 8/0 · US DOMESTIC · CUSIP 45780VAB8

2 institutional holders -2 vs Q1 2020
$4.0mprincipal reported held*
$4.4mreported value*
0 new 0 added 0 reduced 2 sold out net sold ≈ $10.3m

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.

Trends to Q2 2020

Institutional holders

Managers reporting a position, each quarter

0510Q4 19: 9Q1 20: 4Q2 20: 22Q4 19Q1 20Q2 20
Numbers
QuarterHolders
Q4 20199
Q1 20204
Q2 20202

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
505Q1 20: 0 bought or addedQ1 20: 5 cut or sold outQ1 20Q2 20: 0 bought or addedQ2 20: 2 cut or sold outQ2 20
Numbers
QuarterBought or addedCut or sold out
Q1 202005
Q2 202002

Biggest buyers

None

Biggest sellers

WOLVERINE ASSET MANAGEMENT LLC Sold out -7,500,000-7.5m
Bruce & Co., Inc. Sold out -2,000,000-2.0m

Holders, Q2 2020

#ManagerLocationShares Value% of their portfolioChangeShares change
1 DEUTSCHE BANK AG\ 0.00% of their portfolio FRANKFURT AM MAIN, 2M 4,000,0004.0m $4.4m $4.4m 0.00% Unchanged
2 CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio BIRMINGHAM, AL 00 $0 $0 0.00% Unchanged